Search

Your search keyword '"Revillion F."' showing total 100 results

Search Constraints

Start Over You searched for: Author "Revillion F." Remove constraint Author: "Revillion F."
100 results on '"Revillion F."'

Search Results

1. Value of the loss of heterozygosity to BRCA1 variant classification

3. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

6. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

8. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

9. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

10. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

11. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

12. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

13. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

15. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

16. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

20. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

21. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

32. Functional β-adrenergic receptors in breast cancer cells.

40. Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

41. Value of the loss of heterozygosity to BRCA1 variant classification.

42. Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

43. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

44. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.

45. BRCA Share: A Collection of Clinical BRCA Gene Variants.

46. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.

47. High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer.

48. SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

49. Intestinal colonization with bifidobacteria affects the expression of galectins in extraintestinal organs.

50. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.

Catalog

Books, media, physical & digital resources